Urte Gayko

Insider Reports History

Entity
Individual
Location
C/O Parmacyclics, Inc., 995 East Arques Avenue, Sunnyvale, CA
Signature
/s/ Urte Gayko
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Urte Gayko:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Summit Therapeutics Inc. Director Stock Option (right to buy) 400K $528K $1.32 Apr 25, 2022 Direct

Insider Reports Filed by Urte Gayko

Symbol Company Period Transactions Value $ Form Type Date Filed Role
SMMT Summit Therapeutics Inc. Apr 25, 2022 1 $0 4 Apr 26, 2022 Director
SMMT Summit Therapeutics Inc. Jan 3, 2022 2 $48.1K 4 Jan 5, 2022 Director
SMMT Summit Therapeutics Inc. Nov 3, 2021 2 $0 4 Nov 16, 2021 Director
SMMT Summit Therapeutics Inc. Nov 3, 2021 0 $0 3 Nov 16, 2021 Director